Business Description
Burzynski Research Institute Inc
NAICS : 325412
SIC : 2834
ISIN : US1231591058
Total Employee Number:
1Description
Burzynski Research Institute Inc operates as a research and development facility of Antineoplaston drugs currently being tested for the use in the treatment of cancer, and provides consulting services.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | -33.5 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 4/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -16.3 | |||||
3-Year FCF Growth Rate | -14.5 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 37.34 | |||||
9-Day RSI | 43.22 | |||||
14-Day RSI | 41.92 | |||||
3-1 Month Momentum % | -58.22 | |||||
6-1 Month Momentum % | -72.88 | |||||
12-1 Month Momentum % | -87.29 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.03 | |||||
Quick Ratio | 0.03 | |||||
Cash Ratio | 0.03 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROA % | -91928.57 | |||||
Moat Score | 1 | |||||
Tariff Resilience Score | 7 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | N/A |
N/A
|
N/A
| |||
PE Ratio without NRI | N/A |
N/A
|
N/A
| |||
EV-to-EBIT | -0.53 | |||||
EV-to-EBITDA | -0.53 | |||||
EV-to-FCF | -2.66 | |||||
Earnings Yield (Greenblatt) % | -188.68 | |||||
FCF Yield % | -37.55 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:BZYR
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Burzynski Research Institute Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | - | ||
| Beta | 0.2071 | ||
| 3-Year Sharpe Ratio | -0.16 | ||
| 3-Year Sortino Ratio | -0.23 | ||
| Volatility % | 117.12 | ||
| 14-Day RSI | 41.92 | ||
| 14-Day ATR ($) | 0.000554 | ||
| 20-Day SMA ($) | 0.005243 | ||
| 12-1 Month Momentum % | -87.29 | ||
| 52-Week Range ($) | 0.004 - 0.048 | ||
| Shares Outstanding (Mil) | 131.45 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Burzynski Research Institute Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Burzynski Research Institute Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Burzynski Research Institute Inc Frequently Asked Questions
What is Burzynski Research Institute Inc(BZYR)'s stock price today?
The current price of BZYR is $0.01. The 52 week high of BZYR is $0.05 and 52 week low is $0.00.
When is next earnings date of Burzynski Research Institute Inc(BZYR)?
The next earnings date of Burzynski Research Institute Inc(BZYR) is .
Does Burzynski Research Institute Inc(BZYR) pay dividends? If so, how much?
Burzynski Research Institute Inc(BZYR) does not pay dividend.
Guru Commentaries on OTCPK:BZYR
No articles.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Burzynski Research Institute Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers